Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Silybum Solutions is a Paraguayan pharmaceutical company specializing in the research, cultivation, and industrialization of medical cannabis. The company is one of the few entities officially licensed by the Paraguayan government to produce cannabis-based medicinal products under strict regulatory oversight. Their operations encompass the entire value chain, from controlled cultivation to the manufacturing of pharmaceutical-grade extracts and oils. Silybum Solutions aims to provide high-quality therapeutic options for patients with conditions such as refractory epilepsy and chronic pain within the Latin American market. The company focuses on adhering to Good Manufacturing Practices (GMP) to ensure the standardization and safety of its cannabinoid formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Silybum Solutions Paraguay.